Pharma News, 2018

TOKYO & KENILWORTH, N.

Gout sufferers with major pre-existing heart disease face a higher risk of death if they are treated with the drug febuxostat, a large long-term study has concludedThe risk of death from cardiovascula...

LONDON (Reuters) - AstraZeneca now expects a key lung cancer study of two immunotherapy drugs to produce overall survival results in the second half of 2018, rather than the first half.

March 7, 2018 -- Today, the U.

HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of Endocrinology Drugs market.

PARIS (Reuters) - Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains committed to the medicine despite a health sc...

(Reuters) - Europe’s medicines regulator recommended the immediate suspension and recall of Biogen Inc and AbbVie Inc’s multiple sclerosis drug Zinbryta, following 12 reports of inflammati...

Federal regulators approved the first direct-to-consumer test for the BRCA genes, which increase the risk of breast and ovarian cancer, the agency announced on Tuesday.

СHICAGO — A yearlong study offers rigorous new evidence against using prescription opioids for chronic pain.

Cluster analysis of data from patient groups reveals that diabetes is more complex than the currently identified type 1 and type 2 diabetes.

An experimental HIV antibody has successfully suppressed the deadly virus for six months without additional treatment, a trial in monkeys has found.

ALPHARETTA, Ga.